Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

To assess from a health sector perspective the incremental cost-effectiveness of interventions for generalized anxiety disorder (cognitive behavioural therapy [CBT] and serotonin and noradrenaline reuptake inhibitors [SNRIs]) and panic disorder (CBT, selective serotonin reuptake inhibitors [SSRIs] a...

Descripción completa

Detalles Bibliográficos
Publicado en:Australian & New Zealand Journal of Psychiatry Vol. 38; no. 8; pp. 602 - 613
Autores principales: Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T
Formato: research Journal Article
Publicado: Sage Publications Inc. Aug2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106082473&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106082473
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00048674
        7ZU
      jtl: Australian & New Zealand Journal of Psychiatry
      issn: 00048674
      maglogo: Y
    pubinfo:
      dt: Aug2004
      vid: 38
      iid: 8
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        106082473
        106082473
        2009398109
        10.1080/j.1440-1614.2004.01423.x
        NLM15298582
        106082473
      ppf: 602
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
      aug:
        au:
          Heuzenroeder L
          Donnelly M
          Haby MM
          Mihalopoulos C
          Rossell R
          Carter R
          Andrews G
          Vos T
      sug:
        subj:
          Alcohols Economics
          Antidepressive Agents, Tricyclic Economics
          Anxiety Disorders Economics
          Anxiety Disorders Therapy
          Imipramine Economics
          Mental Health Services Economics
          Panic Disorder Economics
          Panic Disorder Therapy
          Paroxetine Economics
          Psychotherapy Economics
          Serotonin Uptake Inhibitors Economics
          Alcohols Therapeutic Use
          Antidepressive Agents, Tricyclic Therapeutic Use
          Anxiety Disorders Drug Therapy
          Australia
          Cost Benefit Analysis
          Disability Evaluation
          Imipramine Therapeutic Use
          Panic Disorder Drug Therapy
          Paroxetine Therapeutic Use
          Serotonin Uptake Inhibitors Therapeutic Use
          Time Factors
          Human
      ab: To assess from a health sector perspective the incremental cost-effectiveness of interventions for generalized anxiety disorder (cognitive behavioural therapy [CBT] and serotonin and noradrenaline reuptake inhibitors [SNRIs]) and panic disorder (CBT, selective serotonin reuptake inhibitors [SSRIs] and tricyclic antidepressants [TCAs]). The health benefit is measured as a reduction in disability-adjusted life years (DALYs), based on effect size calculations from meta-analyses of randomised controlled trials. An assessment on second stage filters ('equity', 'strength of evidence', 'feasibility' and 'acceptability to stakeholders') is also undertaken to incorporate additional factors that impact on resource allocation decisions. Costs and benefits are calculated for a period of one year for the eligible population (prevalent cases of generalized anxiety disorder/panic disorder identified in the National Survey of Mental Health and Wellbeing, extrapolated to the Australian population in the year 2000 for those aged 18 years and older). Simulation modelling techniques are used to present 95% uncertainty intervals (UI) around the incremental cost-effectiveness ratios (ICERs). Compared to current practice, CBT by a psychologist on a public salary is the most cost-effective intervention for both generalized anxiety disorder (A$6900/DALY saved; 95% UI A$4000 to A$12 000) and panic disorder (A$6800/DALY saved; 95% UI A$2900 to A$15 000). Cognitive behavioural therapy results in a greater total health benefit than the drug interventions for both anxiety disorders, although equity and feasibility concerns for CBT interventions are also greater. Cognitive behavioural therapy is the most effective and cost-effective intervention for generalized anxiety disorder and panic disorder. However, its implementation would require policy change to enable more widespread access to a sufficient number of trained therapists for the treatment of anxiety disorders.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N